Development and characterization of solid lipid nanoparticles for enhancement of oral bioavailability of Raloxifene

Journal of Pharmacy and Bioallied Sciences

Volumn 4, Issue SUPPL., 2012, Pages 14-16

  Divyakant, B Patel ^a   Valay, R Modi ^a   Alok, N Thakkar ^a   Arpita, A Patel ^a   Hetal, P Thakkar ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Drug entrapment; estrogen; solvent emulsification; zeta potential

Indexed keywords

COSURFACTANT; RALOXIFENE; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; CHEMICAL PROCEDURES; CONFERENCE PAPER; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG HALF LIFE; DRUG PENETRATION; DRUG STABILITY; EMULSION; FIRST PASS EFFECT; INTESTINE MUCOSA PERMEABILITY; LIVER METABOLISM; LOW TEMPERATURE SOLIDIFICATION; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PARTICLE SIZE; PARTITION COEFFICIENT; PERCENTAGE DRUG ENTRAPMENT; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; ULTRASONIC EMULSIFICATION; ZETA POTENTIAL;

EID: 84860463126     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.94121     Document Type: Conference Paper

References (3)

1. Zurmuhlen C, Mehnert SW. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur. J. Pharm. Biopharm 1998; 45 (2):149-155.
2. Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev 2001; 47 (2-3):165-196. (Pubitemid 32324113)
3. Mehnert SW, Lucks JS, Müller RH. Solid lipid nanoparticles (SLN) for controlled drug delivery: Production, characterization and sterilization. J. Control. Release 1994; 30 (1): 83-96.